Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F van de Werf

Showing results (191-200 of 290) with videos related to

Pageof 29
Sort By:
International Journal of Cardiac Imaging|September 1, 1993
Experimental validation of a new quantitative method for the analysis of infarct size by cardiac perfusion tomography (SPECT)L Mortelmans, J Nuyts, J Vanhaecke, et al.
European Journal of Nuclear Medicine|November 1, 1995
Regional myocardial blood flow, glucose utilization and contractile function before and after revascularization and ultrastructural findings in patients with chronic coronary artery diseaseA Maes, W Flameng, M Borgers, et al.
Circulation|March 1, 1984
Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technologyF Van de Werf, S R Bergmann, K A Fox, et al.
Journal of the American College of Cardiology|January 12, 2001
Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetateA F Maes, F Van de Werf, L V Mesotten, et al.
American Heart Journal|April 26, 2001
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhageR P Giugliano, C H McCabe, E M Antman, et al.
European Heart Journal|August 1, 1995
Progress culminating from ten years of clinical trials on thrombolysis for acute myocardial infarction. GUSTO-I Steering Committee. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesF Van de Werf, R M Califf, P W Armstrong, et al.
European Heart Journal|March 20, 2003
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?A Hersi, Y Fu, B Wong, et al.
Circulation|October 25, 2000
Enhanced Ca(2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesisK R Sipido, P G Volders, S H de Groot, et al.
Circulation|August 29, 2001
Noninvasive quantification of the contractile reserve of stunned myocardium by ultrasonic strain rate and strainF Jamal, J Strotmann, F Weidemann, et al.
Circulation|May 16, 2000
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trialR M Califf, K S Pieper, K L Lee, et al.
Pageof 29

Showing results (191-200 of 290) with videos related to

Sort By:
Pageof 29
International Journal of Cardiac Imaging|September 1, 1993
Experimental validation of a new quantitative method for the analysis of infarct size by cardiac perfusion tomography (SPECT)L Mortelmans, J Nuyts, J Vanhaecke, et al.
European Journal of Nuclear Medicine|November 1, 1995
Regional myocardial blood flow, glucose utilization and contractile function before and after revascularization and ultrastructural findings in patients with chronic coronary artery diseaseA Maes, W Flameng, M Borgers, et al.
Circulation|March 1, 1984
Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technologyF Van de Werf, S R Bergmann, K A Fox, et al.
Journal of the American College of Cardiology|January 12, 2001
Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetateA F Maes, F Van de Werf, L V Mesotten, et al.
American Heart Journal|April 26, 2001
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhageR P Giugliano, C H McCabe, E M Antman, et al.
European Heart Journal|August 1, 1995
Progress culminating from ten years of clinical trials on thrombolysis for acute myocardial infarction. GUSTO-I Steering Committee. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesF Van de Werf, R M Califf, P W Armstrong, et al.
European Heart Journal|March 20, 2003
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?A Hersi, Y Fu, B Wong, et al.
Circulation|October 25, 2000
Enhanced Ca(2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesisK R Sipido, P G Volders, S H de Groot, et al.
Circulation|August 29, 2001
Noninvasive quantification of the contractile reserve of stunned myocardium by ultrasonic strain rate and strainF Jamal, J Strotmann, F Weidemann, et al.
Circulation|May 16, 2000
Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trialR M Califf, K S Pieper, K L Lee, et al.
Pageof 29